News
A study of more than 100 patients found that immunotherapy can cure a rare type of cancer in various tumor sites without ...
16h
AZoLifeSciences on MSNLipid-Rich Ascites Weakens Immunity in Advanced Ovarian CancerRecent research conducted by scientists in Ireland has revealed the significant role of lipid-rich fluid in the abdomen, ...
For Patients Who Cannot Wait, This Off-the-Shelf CAR NK Treatment for AML Leaves Healthy Cells Alone
First part of a 2-part interview with Stephen Strickland, MD, MSCI, director of leukemia research for Sarah Cannon Research Institute. Strickland recently presented data from a phase 1 trial of ...
NEW YORK - A Ludwig Cancer Research study has identified a key mechanism by which advanced ovarian cancers suppress ...
New research has uncovered how lipid-rich fluid in the abdomen, known as ascites, plays a central role in weakening the body’s immune response in advanced ovarian cancer.
New research led by scientists in Ireland has uncovered how a fat-rich fluid found in the abdomen of ovarian cancer patients ...
New research has uncovered how lipid-rich fluid in the abdomen, known as ascites, plays a central role in weakening the body's immune response in advanced ovarian cancer. The findings offer new ...
Lipid receptor SR-B1 identified as a potential immunotherapy target to boost NK cell antitumor response in advanced ovarian ...
A Ludwig Cancer Research study has identified a key mechanism by which advanced ovarian cancers suppress anti-tumor immune ...
Researchers from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) and local biotechnology company Intra-ImmuSG ...
A recent study published in Engineering has shed new light on the mechanisms underlying the metastasis of head and neck squamous cell carcinoma (HNSCC).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results